A Randomized, Double-Blind, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of GSK573719 Administered Once- and Twice-Daily in Subjects With COPD.
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Umeclidinium (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Apr 2012 Results published in the Respiratory Medicine.
- 26 Oct 2011 Results presented at the 77th Annual Meeting of the American College of Chest Physicians.
- 19 Oct 2011 Results will be presented at the 77th Annual Meeting of the American College of Chest Physicians, according to a GlaxoSmithKline media rease.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History